Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity.
Menendez CA, Mohamed A, Perez-Lemus GR, Weiss AM, Rawe BW, Liu G, Crolais AE, Kenna E, Byléhn F, Alvarado W, Mendels D, Rowan SJ, Tay S, de Pablo JJ.
Menendez CA, et al. Among authors: weiss am.
Molecules. 2023 Sep 15;28(18):6643. doi: 10.3390/molecules28186643.
Molecules. 2023.
PMID: 37764425
Free PMC article.